Baseline Cognition Is Not Associated With Depression Outcomes in Vortioxetine for Major Depressive Disorder: Findings From Placebo-Controlled Trials.
Joshua T JordanLi ShenNicholas J CooperSamantha V GoncalvesMadhukar H TrivediAlan F SchatzbergWei WuAdam J SavitzAmit EtkinPublished in: The Journal of clinical psychiatry (2024)
Conclusions: These findings, taken together, suggest that cognitive function does not moderate depression outcomes in vortioxetine, with results comparable to other antidepressants.